Epigenetic modifications in DNA could mimic oxidative DNA damage: A double-edged sword

DNA Repair

Volumn 32, Issue , 2015, Pages 52-57

  Ito, Shinsuke ^a   Kuraoka, Isao ^b  

^a RIKEN Center for Integrative Medical Sciences   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Base excision repair; Deamination; DNA demethylation; DNA methylation; Mismatch repair; TDG; TET proteins

Indexed keywords

5 CARBOXYLCYTOSINE; 5 FORMYLCYTOSINE; 5 HYDROXYMETHYLCYTOSINE; CYTOSINE; CYTOSINE DERIVATIVE; DIOXYGENASE; DNA DIOXYGENASE; DNA GLYCOSYLTRANSFERASE; THYMINE; UNCLASSIFIED DRUG; 5 METHYLCYTOSINE; 5-CARBOXYLCYTOSINE; 5-FORMYLCYTOSINE; 5-HYDROXYMETHYLCYTOSINE; THYMINE DNA GLYCOSYLASE;

ARTICLE; BASE PAIRING; CPG ISLAND; DEAMINATION; DECARBOXYLATION; DEMETHYLATION; DNA DAMAGE; DNA METHYLATION; DNA MODIFICATION; DNA REPAIR; ENZYME MECHANISM; EPIGENETICS; GENE EXPRESSION REGULATION; HYDROLYSIS; MISMATCH REPAIR; MUTAGENESIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FAMILY; ANALOGS AND DERIVATIVES; BASE MISPAIRING; GENE EXPRESSION; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; MOLECULAR MIMICRY; OXIDATION REDUCTION REACTION;

5-METHYLCYTOSINE; BASE PAIR MISMATCH; CPG ISLANDS; CYTOSINE; DEAMINATION; DNA DAMAGE; DNA METHYLATION; DNA REPAIR; EPIGENESIS, GENETIC; GENE EXPRESSION; HUMANS; MOLECULAR MIMICRY; OXIDATION-REDUCTION; THYMINE DNA GLYCOSYLASE;

EID: 84938210275     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2015.04.013     Document Type: Article

References (61)

1. Smith Z.D., Meissner A. DNA methylation: roles in mammalian development. Nat. Rev. Genet. 2013, 14:204-220. 10.1038/nrg3354.
2. Li E., Bestor T.H., Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992, 69:915-926.
3. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99:247-257.
4. Jones P.A., Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 2002, 3:415-428. 10.1038/nrg816.
5. Lutsenko E., Bhagwat A.S. Principal causes of hot spots for cytosine to thymine mutations at sites of cytosine methylation in growing cells. A model, its experimental support and implications. Mutat. Res. 1999, 437:11-20.
6. Cooper D.N., Youssoufian H. The CpG dinucleotide and human genetic disease. Hum. Genet. 1988, 78:151-155. 10.1007/BF00278187.
7. Deaton A.M., Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011, 25:1010-1022. 10.1101/gad.2037511.
8. Wu H., Zhang Y. Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell 2014, 156:45-68. 10.1016/j.cell.2013.12.019.
9. Kagiwada S., Kurimoto K., Hirota T., Yamaji M., Saitou M. Replication-coupled passive DNA demethylation for the erasure of genome imprints in mice. EMBO J. 2013, 32:340-353. 10.1038/emboj.2012.331.
10. Tahiliani M., Koh K.P., Shen Y., Pastor W.A., Bandukwala H., Brudno Y., et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935. 10.1126/science.1170116.
11. Kriaucionis S., Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009, 324:929-930. 10.1126/science.1169786.
12. Ito S., D'Alessio A.C., Taranova O.V., Hong K., Sowers L.C., Zhang Y. Role of tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010, 466:1129-1133. 10.1038/nature09303.
13. Penn N.W., Suwalski R., O'Riley C., Bojanowski K., Yura R. The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. Biochem. J. 1972, 126:781-790.
14. He Y.-F., Li B.-Z., Li Z., Liu P., Wang Y., Tang Q., et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 2011, 333:1303-1307. 10.1126/science.1210944.
15. Ito S., Shen L., Dai Q., Wu S.C., Collins L.B., Swenberg J.A., et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011, 333:1300-1303. 10.1126/science.1210597.
16. Maiti A., Drohat A.C. Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites. J. Biol. Chem. 2011, 286:35334-35338. 10.1074/jbc.C111.284620.
17. Shen L., Wu H., Diep D., Yamaguchi S., D'Alessio A.C., Fung H.-L., et al. Genome-wide analysis reveals TET- and TDG-dependent 5-methylcytosine oxidation dynamics. Cell 2013, 153:692-706. 10.1016/j.cell.2013.04.002.
18. Xu Y., Wu F., Tan L., Kong L., Xiong L., Deng J., et al. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol. Cell 2011, 42:451-464. 10.1016/j.molcel.2011.04.005.
19. Williams K., Christensen J., Pedersen M.T., Johansen J.V., Cloos P.A.C., Rappsilber J., et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011, 473:343-348. 10.1038/nature10066.
20. Wu H., D'Alessio A.C., Ito S., Xia K., Wang Z., Cui K., et al. Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature 2011, 473:389-393. 10.1038/nature09934.
21. Song C.-X., Szulwach K.E., Dai Q., Fu Y., Mao S.-Q., Lin L., et al. Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell 2013, 153:678-691. 10.1016/j.cell.2013.04.001.
22. Globisch D., Münzel M., Müller M., Michalakis S., Wagner M., Koch S., et al. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS One 2010, 5:e15367. 10.1371/journal.pone.0015367.
23. Spruijt C.G., Gnerlich F., Smits A.H., Pfaffeneder T., Jansen P.W.T.C., Bauer C., et al. Dynamic readers for 5-(hydroxy) methylcytosine and its oxidized derivatives. Cell 2013, 152:1146-1159. 10.1016/j.cell.2013.02.004.
24. Ono R., Taki T., Taketani T., Taniwaki M., Kobayashi H., Hayashi Y. LCX leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11) (q22;q23). Cancer Res. 2002, 62:4075-4080.
25. Abdel-Wahab O., Mullally A., Hedvat C., Garcia-Manero G., Patel J., Wadleigh M., et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 2009, 114:114-147. 10.1182/blood-2009-03-210039.
26. Ko M., Huang Y., Jankowska A.M., Pape U.J., Tahiliani M., Bandukwala H.S., et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010, 468:839-843. 10.1038/nature09586.
27. Lian C.G., Xu Y., Ceol C., Wu F., Larson A., Dresser K. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012, 150:1135-1146.
28. Yang H., Liu Y., Bai F., Zhang J.-Y., Ma S.-H., Liu J., et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 2013, 32:663-669. 10.1038/onc.2012.67.
29. Kudo Y., Tateishi K., Yamamoto K., Yamamoto S., Asaoka Y., Ijichi H., et al. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci. 2012, 103:670-676. 10.1111/j.1349-7006.2012.02213.x.
30. Nakabeppu Y. Cellular levels of 8-oxoguanine in either DNA or the nucleotide pool play pivotal roles in carcinogenesis and survival of cancer cells. Int. J. Mol. Sci. 2014, 15:12543-12557. 10.3390/ijms150712543.
31. Kuraoka I., Endou M., Yamaguchi Y., Wada T., Handa H., Tanaka K. Effects of endogenous DNA base lesions on transcription elongation by mammalian RNA polymerase II. Implications for transcription-coupled DNA repair and transcriptional mutagenesis. J. Biol. Chem. 2003, 278:7294-7299. 10.1074/jbc.M208102200.
32. Kusumoto R., Masutani C., Iwai S., Hanaoka F. Translesion synthesis by human DNA polymerase eta across thymine glycol lesions. Biochemistry 2002, 41:6090-6099.
33. Murata-Kamiya N., Kamiya H., Karino N., Ueno Y., Kaji H., Matsuda A., et al. Formation of 5-formyl-2-deoxycytidine from 5-methyl-2-deoxycytidine in duplex DNA by Fenton-type reactions and gamma-irradiation. Nucleic Acids Res. 1999, 27:4385-4390.
34. Liu S., Wang J., Su Y., Guerrero C., Zeng Y., Mitra D., et al. Quantitative assessment of tet-induced oxidation products of 5-methylcytosine in cellular and tissue DNA. Nucleic Acids Res. 2013, 41:6421-6429. 10.1093/nar/gkt360.
35. Münzel M., Lischke U., Stathis D., Pfaffeneder T., Gnerlich F.A., Deiml C.A., et al. Improved synthesis and mutagenicity of oligonucleotides containing 5-hydroxymethylcytosine, 5-formylcytosine and 5-carboxylcytosine. Chemistry 2011, 17:13782-13788. 10.1002/chem.201102782.
36. Kamiya H., Tsuchiya H., Karino N., Ueno Y., Matsuda A., Harashima H. Mutagenicity of 5-formylcytosine an oxidation product of 5-methylcytosine, in DNA in mammalian cells. J. Biochem. 2002, 132:551-555.
37. Raiber E.-A., Murat P., Chirgadze D.Y., Beraldi D., Luisi B.F., Balasubramanian S. 5-Formylcytosine alters the structure of the DNA double helix. Nat. Struct. Mol. Biol. 2014, 10.1038/nsmb.2936.
38. Kellinger M.W., Song C.-X., Chong J., Lu X.-Y., He C., Wang D. 5-Formylcytosine and 5-carboxylcytosine reduce the rate and substrate specificity of RNA polymerase II transcription. Nat. Struct. Mol. Biol. 2012, 19:831-833. 10.1038/nsmb.2346.
39. Hashimoto H., Hong S., Bhagwat A.S., Zhang X., Cheng X. Excision of 5-hydroxymethyluracil and 5-carboxylcytosine by the thymine DNA glycosylase domain: its structural basis and implications for active DNA demethylation. Nucleic Acids Res. 2012, 40:10203-10214. 10.1093/nar/gks845.
40. Neddermann P., Jiricny J. The purification of a mismatch-specific thymine-DNA glycosylase from HeLa cells. J. Biol. Chem. 1993, 268:21218-21224.
41. Neddermann P., Jiricny J. Efficient removal of uracil from G.U. mispairs by the mismatch-specific thymine DNA glycosylase from HeLa cells. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:1642-1646.
42. Zhang L., Lu X., Lu J., Liang H., Dai Q., Xu G.-L., et al. Thymine DNA glycosylase specifically recognizes 5-carboxylcytosine-modified DNA. Nat. Chem. Biol. 2012, 8:328-330. 10.1038/nchembio.914.
43. Cortázar D., Kunz C., Selfridge J., Lettieri T., Saito Y., MacDougall E., et al. Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability. Nature 2011, 470:419-423. 10.1038/nature09672.
44. Cortellino S., Xu J., Sannai M., Moore R., Caretti E., Cigliano A., et al. Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell 2011, 146:67-79. 10.1016/j.cell.2011.06.020.
45. Millar C.B., Guy J., Sansom O.J., Selfridge J., MacDougall E., Hendrich B., et al. Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. Science 2002, 297:403-405. 10.1126/science.1073354.
46. Kemmerich K., Dingler F.A., Rada C., Neuberger M.S. Germline ablation of SMUG1 DNA glycosylase causes loss of 5-hydroxymethyluracil- and UNG-backup uracil-excision activities and increases cancer predisposition of Ung-/-Msh2-/- mice. Nucleic Acids Res. 2012, 40:6016-6025. 10.1093/nar/gks259.
47. Müller U., Bauer C., Siegl M., Rottach A., Leonhardt H. TET-mediated oxidation of methylcytosine causes TDG or NEIL glycosylase dependent gene reactivation. Nucleic Acids Res. 2014, 42:8592-8604. 10.1093/nar/gku552.
48. Hazra T.K., Kow Y.W., Hatahet Z., Imhoff B., Boldogh I., Mokkapati S.K., et al. Identification and characterization of a novel human DNA glycosylase for repair of cytosine-derived lesions. J. Biol. Chem. 2002, 277:30417-30420. 10.1074/jbc.C200355200.
49. Krokeide S.Z., Laerdahl J.K., Salah M., Luna L., Cederkvist F.H., Fleming A.M., et al. Human NEIL3 is mainly a monofunctional DNA glycosylase removing spiroimindiohydantoin and guanidinohydantoin. DNA Repair (Amst.) 2013, 12:1159-1164. 10.1016/j.dnarep.2013.04.026.
50. Waters T.R., Gallinari P., Jiricny J., Swann P.F. Human thymine DNA glycosylase binds to apurinic sites in DNA but is displaced by human apurinic endonuclease 1. J. Biol. Chem. 1999, 274:67-74.
51. Shimizu Y. Xeroderma pigmentosum group C protein interacts physically and functionally with thymine DNA glycosylase. EMBO J. 2003, 22:164-173. 10.1093/emboj/cdg016.
52. Shibutani T., Ito S., Toda M., Kanao R., Collins L.B., Shibata M., et al. Guanine-5-carboxylcytosine base pairs mimic mismatches during DNA replication. Sci. Rep. 2014, 4. 10.1038/srep05220.
53. Branch P., Hampson R., Karran P. DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines. Cancer Res. 1995, 55:2304-2309.
54. Karran P., Bignami M. Drug-related killings: a case of mistaken identity. Chem. Biol. 1996, 3:875-879.
55. Schiesser S., Hackner B., Pfaffeneder T., Müller M., Hagemeier C., Truss M., et al. Mechanism and stem-cell activity of 5-carboxycytosine decarboxylation determined by isotope tracing. Angew. Chem. Int. Ed. Engl. 2012, 51:6516-6520. 10.1002/anie.201202583.
56. Inoue A., Shen L., Dai Q., He C., Zhang Y. Generation and replication-dependent dilution of 5fC and 5caC during mouse preimplantation development. Cell Res. 2011, 21:1670-1676. 10.1038/cr.2011.189.
57. Hajkova P., Jeffries S.J., Lee C., Miller N., Jackson S.P., Surani M.A. Genome-wide reprogramming in the mouse germ line entails the base excision repair pathway. Science 2010, 329:78-82. 10.1126/science.1187945.
58. Friedberg E.C., Walker G.C., Siede W., Wood R.D. DNA Repair and Mutagenesis 2005, American Society for Microbiology Press.
59. Jones P.A., Rideout W.M., Shen J.C., Spruck C.H., Tsai Y.C. Methylation, mutation and cancer. BioEssays 1992, 14:33-36. 10.1002/bies.950140107.
60. Morgan H.D., Dean W., Coker H.A., Reik W., Petersen-Mahrt S.K. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J. Biol. Chem. 2004, 279:52353-52360. 10.1074/jbc.M407695200.
61. Nabel C.S., Jia H., Ye Y., Shen L., Goldschmidt H.L., Stivers J.T., et al. AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation. Nat. Chem. Biol. 2012, 8:751-758. 10.1038/nchembio.1042.